Epstein-Barr virus (EBV) LMP2A alters normal transcriptional regulation following B-cell receptor activation (Q45306307)

11 December 2017

Epstein-Barr virus (EBV) LMP2A alters normal transcriptional regulation following B-cell receptor activation (English)

1 reference

11 December 2017

0 references

2

Richard Longnecker

1 reference

11 December 2017

Toni Portis

1

1 reference

PubMed ID

14972521

11 December 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

11 December 2017

1 reference

11 December 2017

318

1 reference

11 December 2017

2

1 reference

11 December 2017

524-533

1 reference

Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals

11 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.017

Epstein-Barr virus LMP2A-induced B-cell survival in two unique classes of EmuLMP2A transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.017

Epstein-Barr virus coopts lipid rafts to block the signaling and antigen transport functions of the BCR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.017

Epstein-Barr virus latent membrane protein 2A (LMP2A) employs the SLP-65 signaling module

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.017

The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.017

Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.017

LMP2A survival and developmental signals are transmitted through Btk-dependent and Btk-independent pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.017

The LMP2A ITAM is essential for providing B cells with development and survival signals in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.017

An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.017

Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.017

Epstein-Barr virus LMP2A interferes with global transcription factor regulation when expressed during B-lymphocyte development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.017

Epstein-Barr virus: exploiting the immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.017

An Epstein-Barr virus transformation-associated membrane protein interacts with src family tyrosine kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.017

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2003.09.017

1 reference

11 December 2017

1 reference

PubMed ID

14972521